Application 201277
- Type
- NDA
- Sponsor
- BAYER HLTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GADAVIST | GADOBUTROL | SOLUTION;INTRAVENOUS | 4.5354GM/7.5ML (604.72MG/ML) | Yes | Yes |
| 002 | GADAVIST | GADOBUTROL | SOLUTION;INTRAVENOUS | 6.0472GM/10ML (604.72MG/ML) | Yes | Yes |
| 003 | GADAVIST | GADOBUTROL | SOLUTION;INTRAVENOUS | 9.0708GM/15ML (604.72MG/ML) | Yes | Yes |
| 004 | GADAVIST | GADOBUTROL | SOLUTION;INTRAVENOUS | 18.1416GM/30ML (604.72MG/ML) | Yes | Yes |
| 005 | GADAVIST | GADOBUTROL | SOLUTION;INTRAVENOUS | 39.3068GM/65ML (604.72MG/ML) | Yes | Yes |
| 006 | GADAVIST | GADOBUTROL | SOLUTION;INTRAVENOUS | 1.20944GM/2ML (604.72MG/ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N201277-001 | GADAVIST | GADOBUTROL | 4.5354GM/7.5ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 |
| N201277-002 | GADAVIST | GADOBUTROL | 6.0472GM/10ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 |
| N201277-003 | GADAVIST | GADOBUTROL | 9.0708GM/15ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 |
| N201277-004 | GADAVIST | GADOBUTROL | 18.1416GM/30ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 |
| N201277-005 | GADAVIST | GADOBUTROL | 39.3068GM/65ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 |
| N201277-006 | GADAVIST | GADOBUTROL | 1.20944GM/2ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2013-12-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N201277-001 | AP |
| N201277-002 | AP |
| N201277-003 | AP |
| N201277-004 | AP |
| N201277-005 | AP |
| N201277-006 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N201277-001 | GADAVIST | 4.5354GM/7.5ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201277-002 | GADAVIST | 6.0472GM/10ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201277-003 | GADAVIST | 9.0708GM/15ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201277-004 | GADAVIST | 18.1416GM/30ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201277-005 | GADAVIST | 39.3068GM/65ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201277-006 | GADAVIST | 1.20944GM/2ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2013-12-18 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201277-001 | GADAVIST | 4.5354GM/7.5ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201277-002 | GADAVIST | 6.0472GM/10ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201277-003 | GADAVIST | 9.0708GM/15ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201277-004 | GADAVIST | 18.1416GM/30ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201277-005 | GADAVIST | 39.3068GM/65ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201277-006 | GADAVIST | 1.20944GM/2ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2013-12-18 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N201277-001 | GADAVIST | 4.5354GM/7.5ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201277-002 | GADAVIST | 6.0472GM/10ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201277-003 | GADAVIST | 9.0708GM/15ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201277-004 | GADAVIST | 18.1416GM/30ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201277-005 | GADAVIST | 39.3068GM/65ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201277-006 | GADAVIST | 1.20944GM/2ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2013-12-18 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201277-001 | GADAVIST | 4.5354GM/7.5ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201277-002 | GADAVIST | 6.0472GM/10ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201277-003 | GADAVIST | 9.0708GM/15ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201277-004 | GADAVIST | 18.1416GM/30ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201277-005 | GADAVIST | 39.3068GM/65ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201277-006 | GADAVIST | 1.20944GM/2ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2013-12-18 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201277-001 | GADAVIST | 4.5354GM/7.5ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201277-002 | GADAVIST | 6.0472GM/10ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201277-003 | GADAVIST | 9.0708GM/15ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201277-004 | GADAVIST | 18.1416GM/30ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201277-005 | GADAVIST | 39.3068GM/65ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201277-006 | GADAVIST | 1.20944GM/2ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2013-12-18 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201277-001 | GADAVIST | 4.5354GM/7.5ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201277-002 | GADAVIST | 6.0472GM/10ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201277-003 | GADAVIST | 9.0708GM/15ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201277-004 | GADAVIST | 18.1416GM/30ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201277-005 | GADAVIST | 39.3068GM/65ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201277-006 | GADAVIST | 1.20944GM/2ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2013-12-18 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201277-001 | GADAVIST | 4.5354GM/7.5ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201277-002 | GADAVIST | 6.0472GM/10ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201277-003 | GADAVIST | 9.0708GM/15ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201277-004 | GADAVIST | 18.1416GM/30ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | RLD, RS | 2011-03-14 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N201277-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201277-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201277-003 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201277-004 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201277-005 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201277-006 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201277-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201277-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201277-003 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201277-004 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201277-005 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201277-006 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N201277-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201277-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201277-003 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201277-004 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201277-005 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201277-006 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201277-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201277-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201277-003 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201277-004 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201277-005 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201277-006 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201277-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201277-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201277-003 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201277-004 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201277-005 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201277-006 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201277-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201277-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201277-003 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201277-004 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201277-005 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201277-006 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201277-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201277-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201277-003 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201277-004 | AP | 1 | 2680178bc6a6… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N201277-006 | 5980864 | 2021-11-09 | U-1119 | Drug substance, Drug product | 2016-03-17 | 74a2ff9319b5… |
| 2021-12-28 21:50 UTC | 2021-12 | N201277-006 | 5980864 | 2021-11-09 | U-1119 | Drug substance, Drug product | 2016-03-17 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N201277-006 | 5980864 | 2021-11-09 | U-1119 | Drug substance, Drug product | 2016-03-17 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N201277-006 | 5980864 | 2021-11-09 | U-1119 | Drug substance, Drug product | 2016-03-17 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N201277-006 | 5980864 | 2021-11-09 | U-1119 | Drug substance, Drug product | 2016-03-17 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N201277-006 | 5980864 | 2021-11-09 | U-1119 | Drug substance, Drug product | 2016-03-17 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N201277-006 | 5980864 | 2021-11-09 | U-1119 | Drug substance, Drug product | 2016-03-17 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N201277-006 | 5980864 | 2021-11-09 | U-1119 | Drug substance, Drug product | 2016-03-17 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N201277-006 | 5980864 | 2021-11-09 | U-1119 | Drug substance, Drug product | 2016-03-17 | ea99ee380514… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N201277-001 | I-801 | 2022-07-12 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N201277-002 | I-801 | 2022-07-12 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N201277-003 | I-801 | 2022-07-12 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N201277-004 | I-801 | 2022-07-12 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N201277-005 | I-801 | 2022-07-12 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N201277-006 | I-801 | 2022-07-12 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N201277-001 | I-801 | 2022-07-12 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N201277-002 | I-801 | 2022-07-12 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N201277-003 | I-801 | 2022-07-12 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N201277-004 | I-801 | 2022-07-12 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N201277-005 | I-801 | 2022-07-12 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N201277-006 | I-801 | 2022-07-12 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N201277-001 | I-801 | 2022-07-12 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N201277-002 | I-801 | 2022-07-12 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N201277-003 | I-801 | 2022-07-12 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N201277-004 | I-801 | 2022-07-12 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N201277-005 | I-801 | 2022-07-12 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N201277-006 | I-801 | 2022-07-12 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N201277-001 | I-801 | 2022-07-12 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N201277-002 | I-731 | 2019-04-27 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N201277-002 | I-801 | 2022-07-12 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N201277-003 | I-801 | 2022-07-12 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N201277-004 | I-801 | 2022-07-12 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N201277-005 | I-801 | 2022-07-12 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N201277-006 | I-801 | 2022-07-12 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N201277-001 | I-801 | 2022-07-12 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N201277-002 | I-801 | 2022-07-12 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N201277-003 | I-801 | 2022-07-12 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N201277-004 | I-801 | 2022-07-12 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N201277-005 | I-801 | 2022-07-12 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N201277-006 | I-801 | 2022-07-12 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N201277-001 | I-801 | 2022-07-12 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N201277-002 | I-801 | 2022-07-12 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N201277-003 | I-801 | 2022-07-12 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N201277-004 | I-801 | 2022-07-12 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N201277-005 | I-801 | 2022-07-12 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N201277-006 | I-801 | 2022-07-12 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N201277-001 | I-801 | 2022-07-12 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N201277-002 | I-801 | 2022-07-12 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N201277-003 | I-801 | 2022-07-12 | 87673890dc5c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gadavist | GADOBUTROL | Bayer HealthCare Pharmaceuticals Inc. | 3c5101a0-0c7e-4078-8dc3-a57beb9a0e92 | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | 201277 NDA201277 50419-325 |
| Gadavist | GADOBUTROL | Bayer HealthCare Pharmaceuticals Inc. | b7afe34d-b70f-41a5-b89c-561bdf29f046 | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | 201277 NDA201277 50419-325 |
| Gadavist | GADOBUTROL | Bayer HealthCare Pharmaceuticals Inc. | bd28560f-de4d-4140-874e-31df823f4dbb | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | 201277 NDA201277 50419-325 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-325 | Gadavist | gadobutrol | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85094 | SUPPL | 2026-03-23 |
| 85095 | SUPPL | 2026-02-20 |
| 85050 | SUPPL | 2026-02-18 |
| 81494 | SUPPL | 2025-03-07 |
| 81453 | SUPPL | 2025-03-06 |
| 79196 | SUPPL | 2024-07-24 |
| 79180 | SUPPL | 2024-07-24 |
| 77345 | SUPPL | 2024-01-29 |
| 77338 | SUPPL | 2024-01-29 |
| 71104 | SUPPL | 2022-05-20 |
| 71103 | SUPPL | 2022-05-20 |
| 64182 | SUPPL | 2020-08-03 |
| 64181 | SUPPL | 2020-08-03 |
| 64152 | SUPPL | 2020-07-31 |
| 59332 | SUPPL | 2019-07-15 |
| 59325 | SUPPL | 2019-07-12 |
| 59324 | SUPPL | 2019-07-12 |
| 56456 | SUPPL | 2018-11-15 |
| 56305 | SUPPL | 2018-11-06 |
| 55038 | SUPPL | 2018-07-30 |
| 55023 | SUPPL | 2018-07-27 |
| 55022 | SUPPL | 2018-07-27 |
| 53909 | SUPPL | 2018-05-01 |
| 53854 | SUPPL | 2018-04-27 |
| 18998 | SUPPL | 2016-05-05 |
| 9874 | SUPPL | 2016-04-28 |
| 18997 | SUPPL | 2015-09-21 |
| 9873 | SUPPL | 2015-08-03 |
| 40057 | SUPPL | 2015-01-05 |
| 9872 | SUPPL | 2014-12-31 |
| 9871 | SUPPL | 2014-06-12 |
| 40056 | SUPPL | 2013-10-21 |
| 32090 | SUPPL | 2013-10-18 |
| 9870 | SUPPL | 2012-03-26 |
| 44833 | ORIG | 2011-04-11 |
| 22848 | ORIG | 2011-04-11 |
| 32089 | ORIG | 2011-03-16 |
| 40055 | ORIG | 2011-03-15 |
| 66905 | ORIG | 1900-01-01 |
| 66904 | ORIG | 1900-01-01 |
| 66903 | ORIG | 1900-01-01 |
| 54108 | ORIG | 1900-01-01 |
| 54107 | ORIG | 1900-01-01 |
| 51135 | SUPPL | 1900-01-01 |
| 51134 | SUPPL | 1900-01-01 |
| 51133 | SUPPL | 1900-01-01 |